Achondroplasia Berulang pada Orangtua dengan Perawakan Normal: Laporan Kasus

Fatima Zahra; Adhi Pribadi

doi:10.24198/obgynia/v6.n2.479

Achondroplasia Berulang pada Orangtua dengan Perawakan Normal: Laporan Kasus

Fatima Zahra,^(1*) Adhi Pribadi,⁽²⁾

(1) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Padjajaran, Rumah Sakit Dr. Hasan Sadikin, Bandung
(2) Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Padjajaran, Rumah Sakit Dr. Hasan Sadikin, Bandung
(*) Corresponding Author

Abstract

Achondroplasia adalah penyebab paling umum dari perawakan pendek yang tidak proporsional. Individu yang terkena memiliki pemendekan rhizomelia pada anggota badan, makrosefali, dan fitur wajah yang khas. Diagnosis achondroplasia dapat ditegakkan dengan temuan klinis dan radiografi yang khas pada sebagian besar individu yang terkena. Identifikasi varian patogen heterozigot pada FGFR3 dapat membantu menegakkan diagnosis. Kejadian rekurensi achondroplasia pada orangtua dengan perawakan normal sangat jarang terjadi. Pada presentasi kasus ini, kami melaporkan achondroplasia berulang pada orangtua dengan perawakan normal, dengan ditemukan mutasi pada gen FGFR3.

Recurrent Achondroplasia in Average Stature Parents : A Case Report

Abstract

Achondroplasia is the most common cause of disproportionate short stature. Affected individuals have rhizomelic shortening of the limbs, macrocephaly, and characteristic facial features. Achondroplasia can be diagnosed by characteristic clinical and radiographic findings in most affected individuals. Identification of a heterozygous pathogenic variant in FGFR3 can establish the diagnosis. Recurrent achondroplasia in average stature parents is a very rare case. In this case presentation, we report recurrent achondroplasia in average stature parents with proven mutation of FGFR3 gene mutation.

Keyword: recurrent achondroplasia, FGFR3 mutation

Keywords

achondroplasia berulang, mutasi FGFR3

Full Text:

PDF

References

Legare JM. Achondroplasia 1998 [December 1st, 2022]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1152/.

Mettler G, Fraser FC. Recurrence risk for sibs of children with “sporadic” achondroplasia. Am J Med Genet. 2000;90:250-1.

Anbumani TL, Anthony Ammal S, Thamarai Selvi A. A case report of recurrent achondroplasia in fetuses of normal parents. Int J Res Med Sci. 2015;3(6):1533-7.

Chen H. Atlas of genetic diagnosis and counseling. New York: Springer; 2012.

Shiang R, Thompson IM, Zhu YZ, Church DM, Fielder TJ, Bocian M, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. 78. 1994:335-42.

Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis. 2019;3(14):1-49.

Laederich MB, Horton WA. Achondroplasia: pathogenesis and implications for future treatment. Curr Opin Pediatr. 2010;22:516-23.

Goriely A, Wilkie AO. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet. 2012;90:175-200.

Arnheim N, Calabrese P. Germline stem cell competition, mutation hot spots, genetics disorders, and older fathers. Annu Rev Genom Hum Genet. 2016;17:219-43.

Sobetzko D, Braga S, Rüdeberg A, Superti-Furga A. Achondroplasia with the FGFR3 1138 g->a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father. J Med Genet. 2000;37:958-9.

Yoon SR, Choi SK, Eboreime J, Gelb BD, Calabrese P, Arnheim N. Agedependent germline mosaicism of the most common Noonan syndrome mutation shows the signature of germline selection. Am J Hum Genet. 2013;92(6):917-26.

Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 1996;15:520-7.

Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat. 2012;33:29-41.

Savarirayan R, Ireland P, Irving M, Thompson D, Alves I, Baratela WAR, et al. International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia. Nat Rev Endocrinol. 2022;18(3):173-89.

DOI: http://dx.doi.org/10.24198/obgynia/v6.n2.479